Rtw Investments, LP Atara Biotherapeutics, Inc. Transaction History

Rtw Investments, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 14, 2018	SELL	$18.0 - $48.35 $10 Million - $26.9 Million	-556,118 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$13.2 - $18.1 $1.32 Million - $1.81 Million	-99,900 Reduced 15.23%	556,118 $10.1 Million
Q3 2017 Nov 14, 2017	BUY	$13.25 - $17.05 $8.69 Million - $11.2 Million	656,018	656,018 $10.9 Million

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.13B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.